Michael H. Carrel, President, CEO, & Director at AtriCure, Inc. (ATRC), sold 25,000 shares at $32.00 ($800K) on 2019-07-10, disclosed to the SEC on 2019-07-12.
Seasonal sale ($800k) by President, CEO, & Director — this insider has traded ATRC in July in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| ATRC | SELL | 2021-02-04 | $1.5M | — | Filing → |
| ATRC | SELL | 2021-01-13 | $1.5M | — | Filing → |
| ATRC | SELL | 2020-12-28 | $1.4M | — | Filing → |